医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
13期
185-185
,共1页
恶性胸腔积液%顺铂%香菇多糖%微创置管
噁性胸腔積液%順鉑%香菇多糖%微創置管
악성흉강적액%순박%향고다당%미창치관
Malignant pleural effusion%Cisplatin%Lentinan
目的：探讨微创置管引流合用胸腔内注射顺铂+香菇多糖治疗恶性胸腔积液的疗效和毒副作用。方法：将70例恶性胸腔积液患者随机分为观察组(35例)和对照组(35例)，观察组35例患者胸水引流完后经胸腔内注入顺铂+香菇多糖进行治疗；对照组35例患者胸水引流完后经胸腔内注入单用顺铂进行治疗，比较两组疗效。结果：观察组的有效率明显高于对照组，差异具有统计学意义(P<0.05)。结论：顺铂联合香菇多糖治疗恶性胸腔积液患者疗效优于单用顺铂治疗，且微创置管具有创伤小、操作方面、痛苦少等特点。
目的：探討微創置管引流閤用胸腔內註射順鉑+香菇多糖治療噁性胸腔積液的療效和毒副作用。方法：將70例噁性胸腔積液患者隨機分為觀察組(35例)和對照組(35例)，觀察組35例患者胸水引流完後經胸腔內註入順鉑+香菇多糖進行治療；對照組35例患者胸水引流完後經胸腔內註入單用順鉑進行治療，比較兩組療效。結果：觀察組的有效率明顯高于對照組，差異具有統計學意義(P<0.05)。結論：順鉑聯閤香菇多糖治療噁性胸腔積液患者療效優于單用順鉑治療，且微創置管具有創傷小、操作方麵、痛苦少等特點。
목적：탐토미창치관인류합용흉강내주사순박+향고다당치료악성흉강적액적료효화독부작용。방법：장70례악성흉강적액환자수궤분위관찰조(35례)화대조조(35례)，관찰조35례환자흉수인류완후경흉강내주입순박+향고다당진행치료；대조조35례환자흉수인류완후경흉강내주입단용순박진행치료，비교량조료효。결과：관찰조적유효솔명현고우대조조，차이구유통계학의의(P<0.05)。결론：순박연합향고다당치료악성흉강적액환자료효우우단용순박치료，차미창치관구유창상소、조작방면、통고소등특점。
Objective:To explore curative effect of cisplatin and lentinan on malignant pleural effusion. Method:74cases of patients with malignant pleural effusion were randomly divided into observation group (37 cases) and control group (37 cases) . In observation group , 37cases were intrathoracical y injected with cisplatin and lentinan after pleural effusions were drained , and in the control , patients received cisplatin intrathoracical y only. Result: The response rate in observation group was 85.5%, significantly higher than that of the control group (45.7%) , P <0.05.Conclusion: Cisplatin and lentinan have confirmed effects on the patients with malignant pleural effusion.
